|Articles|September 18, 2019
Understanding 21 CFR Part 11/Annex 11 Compliance
Author(s)LabVantage Solutions Inc.
Learn how regulators define temporary memory and how to maintain data integrity. Find out what to look for in a LIMS for 21 CFR Part 11 and Annex 11 compliance.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
4
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
5